Essilor Pharmaceuticals Partnering Deals and Alliances 2010 to 2016

Publisher Name :
Date: 01-Nov-2016
No. of pages: 100
Inquire Before Buying

"Delivery of this report will take 1-3 days after purchase."

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world's leading life sciences companies.

On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.

The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service.

One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.

Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company's business development objectives.

The initial chapters of this report provide an orientation of deal making and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 lists the top companies partnering with the company since 2010. Chapter 3 provides an overview of the leading partnering and M&A deals since 2010 to present date based on headline value.

Chapter 4 provides details on how to approach biopharma companies with partnering opportunities whilst chapter 5 lists forthcoming partnering events and conferences where biopharma companies will be present to discuss opportunities face to face.

The main body of the report is provided in chapter 6 providing a infographic visual summary of the company‘s partnering activity since 2010 according to deal type, industry sector, phase of development, and therapy area.

The deals are listed by deal type, stage of development and therapy focus, allowing easy access to deals and alliances of interest. Every deal record links to an online, live version of the deal record at the Current Agreements deals and alliances database. Where available, deal records also include the contract document as disclosed at the SEC.

One of the key aspects of partnering is conducting due diligence on a partner to determine under what terms a prospective partner agrees to a partnering relationship.

Understanding the flexibility of prospective partners' negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

In addition, contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Each contract document is accessible through a link to an online version of the actual contract document as filed with the Securities Exchange Commission. Analyzing actual company agreements allows assessment of the following:

o What is actually granted by the agreement to the partner company?

o What exclusivity is granted?

o What is the payment structure for the deal?

o How are sales and payments audited?

o What is the deal term?

o How are the key terms of the agreement defined?

o How are IPRs handled and owned?

o Who is responsible for commercialization?

o Who is responsible for development, supply, and manufacture?

o How is confidentiality and publication managed?

o How are disputes to be resolved?

o Under what conditions can the deal be terminated?

o What happens when there is a change of ownership?

o What sublicensing and sub-contracting provisions have been agreed?

o Which boilerplate clauses does the company insist upon?

o Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

o Which jurisdiction does the company insist upon for agreement law?

Partnering Deals and Alliances since 2010 report provides the user with the following key benefits:

Partnering interests and therapy focus revealed

Partnering activity since 2010 - number of deals per year

Partnering activity for 2010-present

Activity by deal type

Activity by phase of development

Activity by therapeutic area

List of recent partner companies

Detailed listing of all partnering deals since 2010

Comprehensive access to actual contracts entered into by the company and its partners*

Insight into the terms included in a partnering agreement

Understand the key deal terms the company has agreed in previous deals

Undertake due diligence to assess suitability of your proposed deal terms for partner companies

*Subject to being published via regulatory requirements of the Securities Exchange Commission.

Essilor Pharmaceuticals Partnering Deals and Alliances 2010 to 2016

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Most active partner companies
2.1 Most frequent partner companies

Chapter 3 - Top deals by value
3.1 M&A
3.2 Partnering

Chapter 4 - Submitting Opportunities
4.1 How to submit an opportunity
4.2 Opportunity submission template
4.3 Sending emails
4.4 Face to face at partnering events
4.5 Online submission forms

Chapter 5 - Forthcoming partnering events
5.1 Forthcoming events

Chapter 6 - Partnering and M&A directory since 2010
6.1 How to use directory
6.3 Company directory
Infographic summary for partnering activity since 2010
Partnering deals directory - by company A-Z
Partnering deals directory - by industry sector
Partnering deals directory - by deal type
Partnering deals directory - M&A
Partnering deals directory - by stage of development
Partnering deals directory - by therapy area
Partnering deals directory - by technology area
About Wildwood Ventures
Current Partnering
Current Agreements
Recent titles from CurrentPartnering

List of Tables and Figures

Figure 1: Most frequent partner companies since 2010
Figure 2: Leading M&A deals by value since 2010
Figure 3: Leading partnering deals by value since 2010
Figure 4: Typical partnering opportunity submission template
Figure 5: Dealmaking frequency since 2010
Figure 6: Recent deals by industry sector
Figure 7: Recent deals by deal type
Figure 8: Recent deals by stage of development
Figure 9: Recent deals by therapy area
Figure 10: Recent deals by technology area
  • Global Active Pharmaceutical Ingredient Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 05-Dec-2016        Price: US 3480 Onwards        Pages: 112
    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active c......
  • Global Epilepsy Drugs Sales Market Report 2016
    Published: 05-Dec-2016        Price: US 4000 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Epilepsy Drugs Revenue, means the sales value of Epilepsy Drugs This report studies sales (consumption) of Epilepsy Drugs in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GlaxoSmithKline - Pfizer - UCB - Eisai - Roche - Shire......
  • Europe Ganciclovir Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Ganciclovir Revenue, means the sales value of Ganciclovir This report studies sales (consumption) of Ganciclovir in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Roche - Bausch & Lomb - Fresenius Kabi - Luitpold - Huatai Pha......
  • Europe Typhoid Vaccine Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 108
    Notes: Sales, means the sales volume of Typhoid Vaccine Revenue, means the sales value of Typhoid Vaccine This report studies sales (consumption) of Typhoid Vaccine in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Bharat Biotech Int. Ltd. (BBIL) - Bio-Med Pvt. Ltd. - PT BioFarm......
  • Europe Trastuzumab Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 109
    Notes: Sales, means the sales volume of Trastuzumab Revenue, means the sales value of Trastuzumab This report studies sales (consumption) of Trastuzumab in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Bristol-Myers Squibb - Eli Lilly and Company - Merck & Co. - Roche......
  • Europe Thromboxane A2 Receptor Antagonist Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Thromboxane A2 Receptor Antagonist Revenue, means the sales value of Thromboxane A2 Receptor Antagonist This report studies sales (consumption) of Thromboxane A2 Receptor Antagonist in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Merck & Co. - ......
  • Europe Salagen Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 101
    Notes: Sales, means the sales volume of Salagen Revenue, means the sales value of Salagen This report studies sales (consumption) of Salagen in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Pfizer - Decartis AG - AstraZeneca PLC - Akorn, Inc. - Genexine - ......
  • Europe Rituxan Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 109
    Notes: Sales, means the sales volume of Rituxan Revenue, means the sales value of Rituxan This report studies sales (consumption) of Rituxan in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Novartis AG - Fujifilm Kyowa Kirin Biologics - AstraZeneca PLC - Marsala Biotech......
  • Europe Prednisolone Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Prednisolone Revenue, means the sales value of Prednisolone This report studies sales (consumption) of Prednisolone in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Pfizer - Merck - Allergan - The Medicines Company - Therava......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs